NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 12 04:00PM ET
19.99
Dollar change
-0.16
Percentage change
-0.79
%
IndexRUT P/E- EPS (ttm)-3.77 Insider Own42.87% Shs Outstand34.04M Perf Week-3.94%
Market Cap680.56M Forward P/E- EPS next Y-3.56 Insider Trans0.00% Shs Float19.45M Perf Month18.56%
Income-127.46M PEG- EPS next Q-0.67 Inst Own58.90% Short Float27.58% Perf Quarter-25.72%
Sales0.00M P/S- EPS this Y-30.21% Inst Trans17.32% Short Ratio26.92 Perf Half Y-42.74%
Book/sh5.95 P/B3.36 EPS next Y-6.75% ROA-46.92% Short Interest5.36M Perf Year15.15%
Cash/sh5.17 P/C3.87 EPS next 5Y4.14% ROE-49.00% 52W Range15.47 - 36.37 Perf YTD-24.96%
Dividend Est.- P/FCF- EPS past 5Y- ROI-62.93% 52W High-45.04% Beta1.47
Dividend TTM- Quick Ratio14.34 Sales past 5Y0.00% Gross Margin- 52W Low29.22% ATR (14)1.32
Dividend Ex-Date- Current Ratio14.34 EPS Y/Y TTM-69.52% Oper. Margin- RSI (14)49.76 Volatility8.33% 6.44%
Employees52 Debt/Eq0.00 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price39.29
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q-265.27% Payout- Rel Volume1.21 Prev Close20.15
Sales Surprise- EPS Surprise-186.14% Sales Q/Q- EarningsMay 12 BMO Avg Volume199.29K Price19.99
SMA20-0.45% SMA501.14% SMA200-19.92% Trades Volume241,124 Change-0.79%
Date Action Analyst Rating Change Price Target Change
Mar-20-25Initiated B. Riley Securities Buy $37
Mar-10-25Initiated Guggenheim Buy $45
Jul-22-24Initiated Oppenheimer Outperform $35
Apr-30-24Initiated H.C. Wainwright Buy $25
Feb-20-24Initiated Jefferies Buy $35
Feb-20-24Initiated Goldman Buy $27
Feb-20-24Initiated Citigroup Buy $30
May-12-25 08:00AM
Apr-28-25 08:00AM
Mar-19-25 04:23PM
Mar-03-25 07:00AM
Jan-23-25 07:05AM
05:00AM Loading…
Jan-22-25 05:00AM
Jan-21-25 07:00PM
Nov-14-24 08:00AM
Oct-11-24 07:02PM
Sep-09-24 12:05PM
Aug-19-24 09:55AM
Aug-14-24 09:54PM
04:01PM
Aug-12-24 08:00AM
Jun-05-24 07:00AM
04:05PM Loading…
May-16-24 04:05PM
May-08-24 12:54PM
08:00AM
Apr-22-24 04:05PM
Mar-28-24 04:05PM
Feb-05-24 12:59PM
Jan-25-24 09:30PM
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company. It focuses on identifying, licensing and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LaChapelle RobinChief Operating OfficerSep 19 '24Option Exercise3.2827,56690,481124,583Sep 23 06:14 PM